[1] MACDONALD IA. A review of recent evidence relating to sugars, insulin resistance and diabetes. Eur J Nutr.2016; 55(2):17-23.
[2] USALA RL, FERNANDEZ SJ, METE M, et al. Hyponatremia is associated with increased osteoporosis and bone fractures in patients with diabetes with matched glycemic control. J Endocr Soc.2019; 3(2):411-426.
[3] ZHOU S, TANG XQ, CHEN HZ. Sirtuins and insulin resistance. Front Endocrinol.2018;9(3):748.
[4] KAYVAN Z, CASSIE JL, ALISON L MC, et al. SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLoS One.2017;12(9):e0185236.
[5] LIU W, ZHANG LQ, XUAN K, et al. Alkaline phosphatase controls Lineage switching of mesenchymal stem cells by regulating the LRP6/GSK3β complex in hypophosphatasia. Theranostics. 2018; 8(20):5575-5592.
[6] MELONI L,VERSTREPEN L,KREIKE M,et al.Mepazine inhibits RANK-induced osteoclastogenesis independent of its MALT1 inhibitory function. Molecules.2018;23(12):3144.
[7] LOMBARDI G, ZIEMANN E, BANFI G. Physical activity and bone health: What is the role of immune system? A narrative review of the third way. Front Endocrinol.2019;10:60.
[8] SPINDLER C, SEGABINAZI E, MEIRELES A, et al. Paternal physical exercise modulates global DNA methylation status in the hippocampus of male rat offspring. Neural Regen Res. 2019;14(3): 491-500.
[9] WANG SS, LUO Q, FAN PH.Cannabisin F from hemp (Cannabis sativa) seed suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia as SIRT1 modulator. Int J Mol Sci. 2019;20(3):507.
[10] RICKERT E, FERNANDEZ MO, CHOI I, et al. Neuronal SIRT1 regulates metabolic and reproductive function and the response to caloric restriction. J Endocr Soc.2019; 3(2):427-445.
[11] JĘŚKO H, WENCEL P, STROSZNAJDER RP, et al. Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res.2017;42(3):876-890.
[12] LIU XF, CAI SY, ZHANG CF, et al. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress. Nucleic Acids Res. 2018;46(18):9601-9616.
[13] ONOFRIO ND,SERVILLO L, BALESTRIERI ML. SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection. Antioxid Redox Signal. 2018; 28(8):711-732.
[14] ABDESSELEM H,MADANI A,HANI A, et al. SIRT1 limits adipocyte hyperplasia through c-myc inhibition. J Biol Chem. 2016; 291(5):2119-2135.
[15] LI MZ, ZHENG LJ, SHEN J, et al. SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes. Neural Regen Res.2018;13(11):2005-2013.
[16] ALI S, NAFIS S, KALAIARASAN P, et al.Understanding genetic heterogeneity in type 2 diabetes by delineating physiological phenotypes: SIRT1 and its gene network in impaired insulin secretion. Rev Diabet Stud.2016;13(1):17-34.
[17] KIM YA, PARK JB, WOO MS, et al. Persistent organic pollutant-mediated insulin resistance. Int J Environ Res Public Health.2019;16(3):448.
[18] AGAS D, GUSMÃO SILVA G, LAUS F, et al. INF-γ encoding plasmid administration triggers bone loss and disrupts bone marrow microenvironment. J Endocrinol.2017; 232 (2):309-321.
[19] ZHANG WL, MENG HZ, YANG RF, et al. Melatonin suppresses autophagy in type 2 diabetic osteoporosis. Oncotarget. 2016; 7(32):52179-52194.
[20] MA XY, CHEN FQ, HONG H, et al. The relationship between serum osteocalcin concentration and glucose and lipid metabolism in patients with type 2 diabetes mellitus-the role of osteocalcin in energy metabolism. Ann Nutr Metab.2015;66(2):110-116.
[21] HAN J, WEI M, WANG Q, et al. Association of genetic variants of SIRT1 with type 2 diabetes mellitus. Gene Expr. 2015;16(4): 177-185.
[22] IYER S, HAN L, BARTELL SM, et al.Sirtuin1 (Sirt1) promotes cortical bone formation by preventing β-catenin sequestration by FoxO transcription factors in osteoblast progenitors. J Biol Chem. 2014;289(35):24069- 24078.
[23] ALBIERO M, PONCINA N, TJWA M, et al. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes.2014; 63(4):1353-1365.
[24] STEPHANIE MC, VIJESH JB, BAO XP, et al. Sucrose non-fermenting related kinase enzyme mediated Rho-associated kinase signaling is responsible for cardiac function. Circ Cardiovasc Genet.2016;9(6):474-486.
[25] MCCARTY MF. AMPK activation-protean potential for boosting healthspan. Age (Dordr). 2014;36(2):641-663.
[26] PEREIRA M, GOHIN S, LUND N, et al. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. Osteoporos Int.2017; 28(1):309-320.
[27] CARLOS VG, ALICE C, AUDREY P, et al. The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis. J Biol Chem.2017;292(35):14505-14515.
[28] QIAO YQ, JIANG PF, GAO YZ.Lutein prevents osteoarthritis through nrf2 activation and downregulation of inflammation. Arch Med Sci. 2018;14(3):617-624.
[29] LIU W, ZHOU L, ZHOU C, et al. GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun.2016;22(7):12794.
[30] LEE SH, PARK Y, SONG M, et al. Orai1 mediates osteogenic differentiation via BMP signaling pathway in bone marrow mesenchymal stem cells. Biochem Biophys Res Commun.2016; 473(4):1309-1314.
[31] PATEL JJ, BUTTERS OR, ARNETT TR.PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity. Cell Biochem Funct. 2014; 32(4):368-377.
[32] GALLAGHER EJ, SUN H, KORNHAUSER C, et al. The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes. Diabetes Metab Res Rev.2014; 30(3):191-200.
[33] FU C, ZHANG X, YE F, et al. High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure. Int J Mol Sci.2015; 16(4):8213-8226.
[34] SHAKIBAEI M, BUHRMANN C, MOBASHERI A. Resveratrol- mediated SIRT-1 interactions with p300 modulate receptor activator of NF-κB ligand(RANKL) activation of NF-κB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem. 2011; 286(13):11492-11505.
[35] SHAKIBAEI M, SHAYAN P, BUSCH F, et al. Resveratrol mediated modulation of Sirt-1/ Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation. PLoS One.2012;7(4):e35712.
[36] TSENG PC, HOU SM, CHEN RJ, et al. Resvertrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1 / FOXO3A axis. J Bone Miner Res.2011;26(10):2552-2563.
[37] BAE SJ, SHIN MW, SON T, et al. Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts. Exp Mol Med. 2019; 51(1):7.
[38] HSIEH YM, LEE WJ, SHEU WH, et al. Inpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients: a retrospective cohort study. Diabetol Metab Syndr.2017;9(3):29-36.
[39] LAURA JL, ANIL KC, AIDI N, et al. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology. Dis Model Mech.2016; 9(10):1169-1179.
[40] TANG YP, LIU JY, YAN YM, et al. 1,25-dihydroxyvitamin-D3 promotes neutrophil apoptosis in periodontitis with type 2 diabetes mellitus patients via the p38/MAPK pathway. Medicine (Baltimore). 2018;97(52):e13903.
[41] KITADA M, KOYA D. SIRT1 in Type 2 Diabetes: mechanisms and therapeutic potential. Diabetes Metab J. 2013; 37(5):315-325.
[42] GONG K, QU B, LIAO D, et al.MiR-132 regulates osteogenic differentiation via downregulating Sirtuin1 in a peroxisome proliferator-activated receptor β/δ-dependent manner. Biochem Biophys Res Commun.2016; 478(1):260-267.
[43] DUCY P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn. 2000;219(4):461-471.
[44] TEIXEIRA CC, LIU Y, THANT LM, et al. Foxo1, a nover regulator of osteoblast differentiation and skeletogenesis. J Biol Chem. 2010;285(40):31055-31065.
[45] DAO DY, JONASON JH, ZHANG YC, et al. Cartilage-specific β-CATENIN signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J Bone Miner Res. 2012; 27(8):1680-1694.
[46] FRANCESCA BL, WILKINSON FL, ALEX WW, et al. The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification. Front Cardiovasc Med. 2018;5:183.
[47] ZHANG L, MENG S, TU QS, et al. Adiponectin ameliorates experimental periodontitis in diet-Induced obesity mice. PLoS One. 2014;9(5):e97824.
[48] CAO X, LI H, TAO H, et al. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology.2013;154(10):3680-3689.
[49] HSIAO EC, MILLARD SM, NISSENSON RA.Gs/Gi Regulation of bone cell differentiation: review and insights from engineered receptors. Horm Metab Res.2016;48(11):689-699.
[50] JIA YH, ZHENG Z, WANG YC, et al. SIRT1 is a regulator in high glucose-induced inflammatory response in raw264.7 cells. PLoS One.2015;10(3):e0120849.
[51] JIA S, HU Y, ZHANG W,et al.Hypoglycemic and hypolipidemic effects of neohesperidin derived from citrus aurantium L in diabetic KK-A(y) mice. Food Funct.2015;6(3):878-886.
[52] 陈祥和,彭海霞,李世昌,等.不同运动方式对Ⅱ型糖尿病小鼠骨形成及BMPs/Smad途径相关分子表达的影响[J].北京体育大学学报, 2017,40(05):51-58.
[53] 陈祥和,彭海霞,孙朋,等.不同力学刺激对T2DM小鼠骨中TGF-β/ Smad途径及骨形成的影响[J].上海体育学院学报,2018,42(3): 95-102.
[54] 陈祥和,孙朋,陈爱国,等.不同运动对2型糖尿病小鼠骨中cAMP/ CREB/ Atf4途径及骨形成的影响[J].中国运动医学杂志,2017,36(11):977-983.
[55] BONEWALD LF. The amazing osteocyte. J Bone Miner Res.2011; 26(2):229-238.
[56] BOYLE WJ, SIMONET WS, LACEY DL. Osteoclast differentiation and activation. Nature.2003;423( 6937):337-342.
[57] 刘波,谢珍,徐彭.Sirt1与骨质疏松症的研究进展[J].中国药理学学报, 2013,29(8):1054-1056.
[58] 李俊.有氧运动对2型糖尿病大鼠血管炎症及SIRT1/NF-κB信号通路的影响[J].北京体育大学学报,2018,41(5):57-63.
[59] ZHANG RK, LI GW, ZENG C, et al. Mechanical stress contributes to osteoarthritis development through the activation of transforming growth factor beta 1 (TGF-β1). Bone Joint Res. 2018;7(11):587-594.
|